Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001047830 | SCV001211812 | pathogenic | Hereditary nonpolyposis colorectal neoplasms | 2024-03-05 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Asn570Lysfs*11) in the PMS2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PMS2 are known to be pathogenic (PMID: 21376568, 24362816). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PMS2-related conditions. ClinVar contains an entry for this variant (Variation ID: 844871). For these reasons, this variant has been classified as Pathogenic. |
Ambry Genetics | RCV002400270 | SCV002713502 | pathogenic | Hereditary cancer-predisposing syndrome | 2020-09-17 | criteria provided, single submitter | clinical testing | The c.1709dupA pathogenic mutation, located in coding exon 11 of the PMS2 gene, results from a duplication of A at nucleotide position 1709, causing a translational frameshift with a predicted alternate stop codon (p.N570Kfs*11). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Baylor Genetics | RCV003467752 | SCV004207882 | likely pathogenic | Lynch syndrome 4 | 2022-10-16 | criteria provided, single submitter | clinical testing |